Japan Science & Technology Agency
In its 13F for Q2 2024 (holdings as of June 30, 2024, filed August 1, 2024), Japan Science & Technology Agency reported 12 stock positions worth $7.2 billion. Its top holding was Ishr Ibx Usd Invgd CB ETF-Ui (LQD) at 20.5% of the portfolio, followed by Vanguard S/T Corp. Bond ETF (VCSH, 17.2%) and Vanguard Int-Term Corporate (VCIT, 13.5%). Compared with Q1 2024, it reduced 2. The biggest sale was Vanguard Int-Term Corporate (VCIT, shares −29%).
- Most Recent 13F
- Q2 2026
- Location
- TOKYO, M0
- CIK
- 0001948391
- Portfolio Value
- $7.2B (Q2 2024)
- SEC Filing
- 0001948391-24-000005 ↗ filed Aug 1, 2024
Holdings Value
Holdings 12 stocks · $7.2B
| LQD Ishr Ibx Usd Invgd CB ETF-Ui | 20.54% | 13,806,450 | $1.5B | No change |
| VCSH Vanguard S/T Corp. Bond ETF | 17.22% | 16,049,666 | $1.2B | Reduce -24.1% |
| VCIT Vanguard Int-Term Corporate | 13.46% | 12,128,000 | $969.4M | Reduce -29.3% |
| HYG Ishr Ibx Usd Hiyld CB ETF-Ui | 11.13% | 10,390,626 | $801.5M | No change |
| IGSB iShares 1-5Y Inv Grade Corp. | 10.96% | 15,409,088 | $789.6M | No change |
| USHY iShares Broad Usd High Yield | 5.61% | 11,130,157 | $403.8M | No change |
| IGIB iShares 5-10Y Inv Grade Corp. | 5.15% | 7,237,448 | $371.0M | No change |
| JNK SS SPDR BB High Yield Bond | 5.05% | 3,858,054 | $363.7M | No change |
| USIG iShares Broad Usd Investment | 5.04% | 7,234,311 | $363.2M | No change |
| SHYG iShares 0-5 YR HY Corp. Bond | 2.97% | 5,070,493 | $214.0M | No change |
| IVV iShares Core S&P 500 ETF | 1.81% | 238,164 | $130.3M | No change |
| SCHD Schwab US DVD Equity ETF | 1.05% | 970,000 | $75.4M | No change |
Portfolio Sells Q1 2024 → Q2 2024
Portfolio Buys Q1 2024 → Q2 2024
| None this quarter. | |||
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 12 | $5.3B | HYG, LQD, IVV, RSP, USHY |
| Q1 2026 | 12 | $4.8B | LQD, HYG, IVV, RSP, USHY |
| Q4 2025 | 12 | $5.4B | LQD, HYG, IVV, RSP, USHY |
| Q3 2025 | 13 | $5.6B | LQD, HYG, IVV, RSP, USHY |
| Q2 2025 | 13 | $6.3B | LQD, HYG, IVV, RSP, VCIT |
| Q1 2025 | 13 | $6.5B | LQD, HYG, IVV, RSP, VCIT |
| Q4 2024 | 11 | $5.8B | LQD, HYG, VCIT, VCSH, IGSB |
| Q3 2024 | 13 | $7.6B | LQD, VCSH, VCIT, HYG, IGSB |
| Q2 2024 | 12 | $7.2B | LQD, VCSH, VCIT, HYG, IGSB |
| Q1 2024 | 12 | $8.1B | VCSH, LQD, VCIT, HYG, IGSB |